NCT04657484View on ClinicalTrials.gov

Comparison of Two Corticosteroid Regimens for Post COVID-19 Diffuse Lung Disease

NACompletedINTERVENTIONAL
Enrollment

130

Participants

Timeline

Start Date

December 1, 2020

Primary Completion Date

September 1, 2021

Study Completion Date

September 1, 2021

Conditions
Post COVID-19 Diffuse Lung Disease
Interventions
DRUG

Medium dose prednisolone

Same as arm description

DRUG

Low dose prednisolone

Same as arm description

Trial Locations (1)

160012

Postgraduate Institute of Medical Education and Research, Chandigarh

All Listed Sponsors
lead

Post Graduate Institute of Medical Education and Research, Chandigarh

OTHER

NCT04657484 - Comparison of Two Corticosteroid Regimens for Post COVID-19 Diffuse Lung Disease | Biotech Hunter | Biotech Hunter